Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 551-557

  Kim, Hee Seung ^a   Kim, Ji Hyun ^a   Chung, Hyun Hoon ^a   Kim, Hak Jae ^a   Kim, Yong Beom ^b   Kim, Jae Weon ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a,c   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Cervical cancer; Metastatic lymph nodes; Neoadjuvant chemotherapy before surgery; Primary surgical treatment; Removed lymph nodes

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 79957458568     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.01.024     Document Type: Article

References (26)

1. WHO. World Health Organization Report: Comprehensive Cervical Cancer Control: a Guide to Essential Practice. World Health organization Web site; 2006. Available at: http://www.who.int/reproductive-health/publications/ cervical-cancer-gep/index.htm. Accessed on November, 2009.
2. K. Kim, and S.Y. Ryu Major clinical research advances in gynecologic cancer 2009 J Gynecol Oncol 20 2009 203 209
3. National Comprehensive Cancer Network. Cervical Cancer Practice Guidelines in Oncology (Version I. 2011). Available at: http://www.nccn.org/ professionals/physician-gls/PDF/cervical.pdf. Accessed on Novemebr, 2010.
4. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
5. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs III Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
6. H.S. Kim, J.Y. Kim, N.H. Park, K. Kim, H.H. Chung, and Y.B. Kim Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer Gynecol Oncol 119 2010 217 224
7. R.G. Stock, A.S. Chen, J.C. Flickinger, S. Kalnicki, and J. Seski Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure Int J Radiat Oncol Biol Phys 31 1995 31 36
8. M. Werner-Wasik, C.H. Schmid, L. Bornstein, H.G. Ball, D.M. Smith, and H. Madoc-Jones Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma Int J Radiat Oncol Biol Phys 32 1995 1309 1317
9. P. Benedetti-Panici, F. Maneschi, G. Scambia, S. Greggi, G. Cutillo, and G. D'Andrea Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy Gynecol Oncol 62 1996 19 24 (Pubitemid 26234540)
10. Q.D. Pieterse, G.G. Kenter, K.N. Gaarenstroom, A.A. Peters, S.M. Willems, and G.J. Fleuren The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer Eur J Surg Oncol 33 2007 216 221 (Pubitemid 46349945)
11. M. Shah, S.N. Lewin, I. Deutsch, W.M. Burker, X. Sun, and T.J. Herzog Therapeutic role of lymphadenectomy for cervical cancer Cancer 117 2010 310 317
12. J.E. Sardi, A. Giaroli, C. Sananes, M. Ferreira, A. Soderini, and A. Bermudez Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol Oncol 67 1997 61 69 (Pubitemid 27433330)
13. H.B. Cai, H.Z. Chen, and H.H. Yin Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer J Obstet Gynaecol Res 32 2006 315 323
14. L. Rydzewska, J. Tierney, C.L. Vale, and P.R. Symonds Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev 2010 CD007406
15. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 1990 352 357 (Pubitemid 20362555)
16. R.A. Samlal, J. van der Velden, M.S. Schilthuis, D. Gonzalez Gonzalez, F.J. Ten Kate, and A.A. Hart Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma Gynecol Oncol 64 1997 463 467 (Pubitemid 27120437)
17. Y. Aoki, M. Sasaki, M. Watanabe, T. Sato, I. Tsuneki, and H. Aida High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation Gynecol Oncol 77 2000 305 309 (Pubitemid 30317154)
18. D.J. Tinga, P.R. Timmer, J. Bouma, and J.G. Aalders Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB Gynecol Oncol 39 1990 175 180 (Pubitemid 20372408)
19. C.H. Lai, H.C. Chang, T.C. Chang, S. Hsueh, and S.G. Tang Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases Gynecol Oncol 51 1993 390 396
20. D.S. Kim, H. Moon, K.T. Kim, Y.Y. Hwang, S.H. Cho, and S.R. Kim Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor Gynecol Oncol 33 1989 225 230 (Pubitemid 19112919)
21. L. Selvaggi, V. Loizzi, D.I. Gilio AR, C. Nardelli, C. Cantatore, and G. Cormio Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience Int J Gynecol Cancer 16 2006 631 637
22. P.B. Panici, G. Scambia, G. Baiocchi, S. Greggi, G. Ragusa, and A. Gallo Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival Cancer 67 1991 372 379
23. H.S. Kim, N.H. Park, H.G. Wu, J.Y. Cho, H.H. Chung, and J.W. Kim Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis Ann Surg Oncol 16 2009 133 139
24. G. Ferrandina, M. Distefano, M. Ludovisi, A. Morganti, D. Smaniotto, and G. D'Agostino Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy Ann Surg Oncol. 14 2007 1129 1135
25. A. Maneo, S. Chiari, C. Bonazzi, and C. Mangioni Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer Gynecol Oncol 111 2008 438 443
26. A. Buda, R. Fossati, N. Colombo, F. Fei, I. Floriani, and D. Gueli Alletti Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative study J Clin Oncol 23 2005 4137 4145 (Pubitemid 46211319)